📰 Life Sciencesnv Nasdaq News
Life Sciencesnv Nasdaq News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Life Sciencesnv Nasdaq. Real-time updates on events, politics, business and more.
December 23, 2022
Investegate announcements from atai Life Sciences, atai Life Sciences Announces Results from the Kures Therapeutics Phase 1 Trial of KUR-101
December 23, 2022
- This two-part phase 1 trial in healthy volunteers was designed to assess the safety, pharmacokinetics, and analgesic activity of KUR-101 - KUR-101 was well tolerated and demonstrated analgesic
November 10, 2022
Investegate announcements from atai Life Sciences, atai Life Sciences Reports Third Quarter 2022 Financial Results and Business Update
November 1, 2022
NEW YORK and BERLIN, Nov. 01, 2022 (GLOBE NEWSWIRE) -- atai Life Sciences N.V. (Nasdaq: ATAI) ("atai"), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders
November 1, 2022
NEW YORK and BERLIN, Nov. 01, 2022 (GLOBE NEWSWIRE) -- atai Life Sciences N.V. (Nasdaq: ATAI) ("atai"), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders
October 12, 2022
Investegate announcements from atai Life Sciences, atai Life Sciences Announces Positive Initial Results for Phase 1 Trial of KUR-101, an Oral Formulation of Mitragynine for OUD
October 5, 2022
Investegate announcements from atai Life Sciences, atai Life Sciences Announces First Subject Dosed in Phase 1 Trial of Buccal and IV VLS-01, a Synthetic Form of DMT
October 5, 2022
- atai has dosed the first subject in their Phase 1 single-ascending dose (SAD) trial of VLS-01 with topline results expected in H1 2023. - VLS-01 is a synthetic form of N,N-dimethyltryptamine (DMT)
October 4, 2022
04.10.2022 - NEW YORK and BERLIN, Oct. 04, 2022 (GLOBE NEWSWIRE) - atai Life Sciences N.V. (Nasdaq: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, will participate in in the following ...
October 4, 2022
Investegate announcements from atai Life Sciences, atai Life Sciences to Participate in October Investor Events & Host Virtual R&D Day